Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study.

Alessio Amatu Gianluca MauriFederica TosiKatia BencardinoErica BonazzinaViviana GoriLorenzo RuggieriSabrina ArenaAlberto BardelliSilvia Marsoni Salvatore Siena Andrea Sartore-Bianchi

Published in: Cancers (2022)

oxaliplatin retreatment produced further RR in around one-fifth of patients and DCR 57.8%. Efficacy decreased in more pre-treated patients and around one-third of patients discontinued treatment due to adverse events. Translational studies improving patient selection are warranted.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
squamous cell carcinoma
case report
replacement therapy
case control